NasdaqGS - Nasdaq Real Time Price USD

Medpace Holdings, Inc. (MEDP)

386.34 +0.64 (+0.17%)
At close: May 31 at 4:00 PM EDT
388.67 +2.33 (+0.60%)
Pre-Market: 9:17 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
1,962,812.00
1,885,842.00
1,459,996.00
1,142,377.00
925,925.00
--
Cost of Revenue
1,413,354.00
1,361,337.00
1,027,558.00
814,222.00
647,199.00
--
Gross Profit
549,458.00
524,505.00
432,438.00
328,155.00
278,726.00
--
Operating Expense
194,768.00
187,680.00
153,741.00
129,540.00
111,684.00
--
Operating Income
354,690.00
336,825.00
278,697.00
198,615.00
167,042.00
--
Net Non Operating Interest Income Expense
4,493.00
-488.00
-2,905.00
-105.00
307.00
--
Other Income Expense
3,251.00
-655.00
7,068.00
3,342.00
1,183.00
--
Pretax Income
362,434.00
335,682.00
282,860.00
201,852.00
168,532.00
--
Tax Provision
49,927.00
52,872.00
37,492.00
20,004.00
23,148.00
--
Net Income Common Stockholders
312,320.00
282,619.00
245,211.00
181,390.00
144,925.00
--
Diluted NI Available to Com Stockholders
312,320.00
282,619.00
245,211.00
181,390.00
144,925.00
--
Basic EPS
10.17
9.20
7.57
5.06
4.07
--
Diluted EPS
9.81
8.88
7.28
4.81
3.84
--
Basic Average Shares
30,680.75
30,722.00
32,388.00
35,862.00
35,635.00
--
Diluted Average Shares
31,802.50
31,841.00
33,671.00
37,697.00
37,708.00
--
Total Operating Income as Reported
354,690.00
336,825.00
278,697.00
198,615.00
167,042.00
--
Total Expenses
1,608,122.00
1,549,017.00
1,181,299.00
943,762.00
758,883.00
--
Net Income from Continuing & Discontinued Operation
312,507.00
282,810.00
245,368.00
181,848.00
145,384.00
--
Normalized Income
314,170.27
284,434.22
242,022.25
179,344.12
144,940.60
--
Interest Expense
--
--
--
--
--
1,568.00
Net Interest Income
4,493.00
-488.00
-2,905.00
-105.00
307.00
--
EBIT
354,690.00
336,825.00
278,697.00
198,615.00
167,042.00
--
EBITDA
382,052.00
363,153.00
301,038.00
219,734.00
186,570.00
--
Reconciled Cost of Revenue
1,413,354.00
1,361,337.00
1,027,558.00
814,222.00
647,199.00
--
Reconciled Depreciation
27,362.00
26,328.00
22,341.00
21,119.00
19,528.00
--
Net Income from Continuing Operation Net Minority Interest
312,507.00
282,810.00
245,368.00
181,848.00
145,384.00
--
Total Unusual Items Excluding Goodwill
-1,929.00
-1,929.00
3,859.00
2,779.00
514.00
--
Total Unusual Items
-1,929.00
-1,929.00
3,859.00
2,779.00
514.00
--
Normalized EBITDA
383,981.00
365,082.00
297,179.00
216,955.00
186,056.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-265.73
-304.78
513.25
275.12
70.60
--
12/31/2019 - 8/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MTD Mettler-Toledo International Inc.
1,404.09
+1.48%
 
ICLR ICON Public Limited Company
324.82
+0.59%
 
IDXX IDEXX Laboratories, Inc.
496.95
-0.56%
 
IQV IQVIA Holdings Inc.
219.09
-1.51%
 
WAT Waters Corporation
308.90
+0.42%
 
TMO Thermo Fisher Scientific Inc.
567.98
+0.93%
 
DHR Danaher Corporation
256.80
+1.61%
 
NTRA Natera, Inc.
106.56
-3.23%
 
CRL Charles River Laboratories International, Inc.
208.44
-0.61%
 
EXAS Exact Sciences Corporation
45.45
+0.44%